{
  "id": "e629b901930fd3b7",
  "title": "STAT+: Structure reports promising weight loss outcomes with obesity drug, but side effect questions loom",
  "description": "An investigational GLP-1 pill from Structure Therapeutics led to substantial weight loss, but patients also had high rates of nausea and vomiting.",
  "content": "An investigational GLP-1 pill from Structure Therapeutics led to substantial weight loss, but patients also had high rates of nausea and vomiting.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/08/structure-obesity-oral-small-molecule-aleniglipron-side-effects/?utm_campaign=rss",
  "published_at": "2025-12-08T14:10:19+00:00",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Structure reports promising weight loss outcomes with obesity drug, but side effect questions loom",
    "description": "An investigational GLP-1 pill from Structure Therapeutics led to substantial weight loss, but patients also had high rates of nausea and vomiting.",
    "url": "https://www.statnews.com/2025/12/08/structure-obesity-oral-small-molecule-aleniglipron-side-effects/?utm_campaign=rss",
    "published": "2025-12-08T14:10:19+00:00",
    "source": "STAT"
  }
}